AcquisitionOther
Alumis Inc. acquired ACELYRIN, INC.
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Alumis Inc. -> ACELYRIN, INC.
Combination to advance expanded late-stage pipeline with financial flexibility and build commercial capabilities for immune-mediated disease therapies.
Open source record (SEC) ↗